Barclays’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-22,791
| Closed | -$127K | – | 5546 |
|
|
2024
Q2 | $127K | Buy |
+22,791
| New | +$80.9K | ﹤0.01% | 3795 |
|
|
2023
Q4 | – | Sell |
-36
| Closed | -$112 | – | 5388 |
|
|
2023
Q3 | $112 | Buy |
+36
| New | +$119 | ﹤0.01% | 4544 |
|
|
2019
Q3 | – | Sell |
-6
| Closed | – | – | 7225 |
|
|
2019
Q2 | $0 | Sell |
6
-36
| -86% | -$507 | ﹤0.01% | 7359 |
|
|
2019
Q1 | $1K | Buy |
42
+36
| +600% | +$548 | ﹤0.01% | 6942 |
|
|
2018
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 7433 |
|
|
2018
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 7456 |
|
|
2018
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 7362 |
|
|
2018
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 7405 |
|
|
2017
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 7168 |
|
|
2017
Q3 | $0 | Hold |
6
| – | – | ﹤0.01% | 7098 |
|
|
2017
Q2 | $0 | Hold |
6
| – | – | ﹤0.01% | 7003 |
|
|
2017
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 7037 |
|
|
2016
Q4 | $0 | Hold |
6
| – | – | ﹤0.01% | 6885 |
|
|
2016
Q3 | $0 | Sell |
6
-198
| -97% | -$4.56K | ﹤0.01% | 6843 |
|
|
2016
Q2 | $4K | Buy |
204
+198
| +3,300% | +$5.26K | ﹤0.01% | 5811 |
|
|
2016
Q1 | $0 | Hold |
6
| – | – | ﹤0.01% | 6500 |
|
|
2015
Q4 | $0 | Sell |
6
-998
| -99% | -$43.3K | ﹤0.01% | 6695 |
|
|
2015
Q3 | $30K | Buy |
1,004
+959
| +2,131% | +$54K | ﹤0.01% | 5286 |
|
|
2015
Q2 | $2K | Sell |
45
-144
| -76% | -$9.93K | ﹤0.01% | 6832 |
|
|
2015
Q1 | $14K | Buy |
189
+74
| +64% | +$5.82K | ﹤0.01% | 6054 |
|
|
2014
Q4 | $8K | Sell |
115
-263
| -70% | -$21.3K | ﹤0.01% | 6837 |
|
|
2014
Q3 | $28K | Buy |
378
+345
| +1,045% | +$29.5K | ﹤0.01% | 6272 |
|
|
2014
Q2 | $2K | Sell |
33
-17
| -34% | -$1.51K | ﹤0.01% | 7427 |
|
|
2014
Q1 | $5K | Buy |
50
+25
| +100% | +$2.43K | ﹤0.01% | 7216 |
|
|
2013
Q4 | $1K | Sell |
25
-17
| -40% | -$693 | ﹤0.01% | 7458 |
|
|
2013
Q3 | $2K | Sell |
42
-17
| -29% | -$1.07K | ﹤0.01% | 7220 |
|
|
2013
Q2 | $4K | Buy |
+59
| New | +$3.41K | ﹤0.01% | 7420 |
|
Barclays's ALIM Position: Q3 2024 in Review
Barclays sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 22,791 shares — an estimated $127K sold.
Barclays first reported a position in ALIM in Q2 2013 and held it in 27 quarters. The position peaked at $127K in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- Barclays reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- Barclays sold 22,791 Alimera Sciences shares in Q3 2024, an estimated $127K.
- Barclays first reported a position in Alimera Sciences in Q2 2013 and held it in 27 quarters.
- Barclays's Alimera Sciences position peaked at $127K in Q2 2024.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.